November 20, 2019
November 14, 2019
Understanding the Various Considerations for EDC Selection
An Interview with Kathleen Boruchowski, Director of Data Management, Veristat
November 6, 2019
October 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development and approval. Below are the relevant links to updates provided in October 2019.